| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |




From the Department of Pathology,* Vrije Universiteit University Medical Center (VUMC), Amsterdam; the Department of Pathology,
Leiden University Medical Center (LUMC), Leiden; Swammerdam Institute for Life Sciences,
Biocentrum Amsterdam, University of Amsterdam, Amsterdam; and the Department of Hematology,
Groningen University Hospital, The Netherlands
Human Polycomb-group (PcG) genes play a crucial role in the regulation of embryonic development and regulation of the cell cycle and hematopoiesis. PcG genes encode proteins that form two distinct PcG complexes, involved in maintenance of cell identity and gene silencing patterns. We recently showed that expression of the BMI-1 and EZH2 PcG genes is separated during normal B-cell development in germinal centers, whereas Hodgkin/Reed-Sternberg (H/RS) cells co-express BMI-1 and EZH2. In the current study, we used immunohistochemistry and immunofluorescence to determine whether the binding partners of these PcG proteins are also present in H/RS cells and H/RS-derived cell lines. PcG expression profiles were analyzed in combination with expression of the cell cycle inhibitor p16INK4a, because experimental model systems indicate that p16 is a downstream target of Bmi-1. We found that H/RS cells and HL-derived cell lines co-express all core proteins of the two known PcG complexes, including BMI-1, MEL-18, RING1, HPH1, HPC1, and -2, EED, EZH2, YY1, and the HPC2 binding partner, CtBP. Expression of HPC1 has not been found in normal mature B cells and other malignant lymphomas of B-cell origin, suggesting that the PcG expression profile of H/RS is unique. In contrast to Bmi-1 transgenic mice where p16INK4a is down-regulated, 27 of 52 BMI-1POS cases of HL revealed strong nuclear expression of p16INK4a. We propose that abnormal expression of BMI-1 and its binding partners in H/RS cells contributes to development of HL. However, abnormal expression of BMI-1 in HL is not necessarily associated with down-regulation of p16INK4a.
This article has been cited by other articles:
![]() |
J.-Y. Lee, K.-S. Jang, D.-H. Shin, M.-Y. Oh, H.-J. Kim, Y. Kim, and G. Kong Mel-18 Negatively Regulates INK4a/ARF-Independent Cell Cycle Progression via Akt Inactivation in Breast Cancer Cancer Res., June 1, 2008; 68(11): 4201 - 4209. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Vekony, F M Raaphorst, A P Otte, M van Lohuizen, C R Leemans, I van der Waal, and E Bloemena High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma J. Clin. Pathol., June 1, 2008; 61(6): 744 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Rajasekhar and M. Begemann Concise Review: Roles of Polycomb Group Proteins in Development and Disease: A Stem Cell Perspective Stem Cells, October 1, 2007; 25(10): 2498 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Miremadi, M. Z. Oestergaard, P. D.P. Pharoah, and C. Caldas Cancer genetics of epigenetic genes Hum. Mol. Genet., April 15, 2007; 16(R1): R28 - R49. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nagel, C. Burek, L. Venturini, M. Scherr, H. Quentmeier, C. Meyer, A. Rosenwald, H. G. Drexler, and R. A. F. MacLeod Comprehensive analysis of homeobox genes in Hodgkin lymphoma cell lines identifies dysregulated expression of HOXB9 mediated via ERK5 signaling and BMI1 Blood, April 1, 2007; 109(7): 3015 - 3023. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dutton, C. B. Woodman, M. B. Chukwuma, J. I. K. Last, W. Wei, M. Vockerodt, K. R. N. Baumforth, J. R. Flavell, M. Rowe, A. M. R. Taylor, et al. Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells Blood, March 15, 2007; 109(6): 2597 - 2603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Silva, J. M. Garcia, C. Pena, V. Garcia, G. Dominguez, D. Suarez, F. I. Camacho, R. Espinosa, M. Provencio, P. Espana, et al. Implication of Polycomb Members Bmi-1, Mel-18, and Hpc-2 in the Regulation of p16INK4a, p14ARF, h-TERT, and c-Myc Expression in Primary Breast Carcinomas Clin. Cancer Res., December 1, 2006; 12(23): 6929 - 6936. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Holmes, K. A. Weedmark, and G. B. Gloor Mutations in the extra sex combs and Enhancer of Polycomb Genes Increase Homologous Recombination in Somatic Cells of Drosophila melanogaster Genetics, April 1, 2006; 172(4): 2367 - 2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mihara, M. Chowdhury, N. Nakaju, S. Hidani, A. Ihara, H. Hyodo, S. Yasunaga, Y. Takihara, and A. Kimura Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis Blood, January 1, 2006; 107(1): 305 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Raaphorst Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R93 - R100. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |